Cargando…

Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403918/
https://www.ncbi.nlm.nih.gov/pubmed/36034990
http://dx.doi.org/10.21037/atm-2022-17
_version_ 1784773488292134912
collection PubMed
description
format Online
Article
Text
id pubmed-9403918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-94039182022-08-26 Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer Ann Transl Med Erratum AME Publishing Company 2022-08 /pmc/articles/PMC9403918/ /pubmed/36034990 http://dx.doi.org/10.21037/atm-2022-17 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Erratum
Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
title Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
title_full Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
title_fullStr Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
title_full_unstemmed Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
title_short Erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
title_sort erratum to development and validation of an individualized gene expression-based signature to predict overall survival in metastatic colorectal cancer
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403918/
https://www.ncbi.nlm.nih.gov/pubmed/36034990
http://dx.doi.org/10.21037/atm-2022-17
work_keys_str_mv AT erratumtodevelopmentandvalidationofanindividualizedgeneexpressionbasedsignaturetopredictoverallsurvivalinmetastaticcolorectalcancer